Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns – Clinical Microbiology and Infection   Commentary on Twitter ⛔A new safety concern⛔New ? post-marketing study @CMIJournal suggests that the use of remdesivir is significantly associated with an increased risk of reporting serious bradycardia compared with HCQ,LPV/RTV, tocilizumab or glucocorticoids #IDTwitter https://t.co/npLMchifEM — […]

The post Serious bradycardia and Remdesivir for COVID-19: a new safety concern appeared first on Links Medicus.